ARTICLE | Clinical News
Recombinant IL-7 regulatory update
October 29, 2012 7:00 AM UTC
Cytheris said FDA granted Orphan Drug designation for CYT107 to treat progressive multifocal leukoencephalopathy (PML). The company plans to begin a pivotal Phase IIb trial of CYT107 to treat HIV-rela...